Nude mouse xenograft tumor formation experiments were employed to further verify the connection between EMP3 expression and trastuzumab resistance.<h4>Results</h4>A total of 90 HER2-enriched breast cancer patients were enrolled in this research. Here, EMP3 is linked to neoplasm.